Savient Pharmaceuticals Receives Complete Response Letter from U.S. Food and Drug Administration for KRYSTEXXA(TM)
... BRUNSWICK, N.J., Aug. 2 /PRNewswire-FirstCall/ --
savient Pharmaceuticals, Inc. (Nasdaq: SVNT ) today anno...esponse letter," stated Paul Hamelin, President of
savient Pharmaceuticals. "While we believe we have made s...ndicated.
Conference Call Information
savient will host a live webcast to discuss the approval o...
The Gout & Uric Acid Education Society (GUAES) Announces New Survey Results Highlighting Major Gaps in Public Awareness of Gout
... support the educational outreach of the Society. Gout Awareness Day sponsorship has been provided by Takeda Pharmaceuticals North America, Inc., and
savient Pharmaceuticals, Inc.
About the Survey
This survey was conducted online within the United States by Harris Interactive from May 5 to May 7 ...
Savient Pharmaceuticals to Present at The Cowen and Company 29th Annual Healthcare Conference on March 17, 2009
...BRUNSWICK, N.J., March 9 /PRNewswire-FirstCall/ --
savient Pharmaceuticals, Inc. (Nasdaq: SVNT ) today announced that Paul Hamelin, President of
savient Pharmaceuticals will be presenting at the upcoming...by logging on to the Investor Relations section of
savient Pharmaceuticals' Web site, http://www.savient.com...
Savient Pharmaceuticals Reports Fourth Quarter and Year-End 2008 Financial Results
...BRUNSWICK, N.J., Feb. 25 /PRNewswire-FirstCall/ --
savient Pharmaceuticals, Inc. (Nasdaq: SVNT ) today repo... on these investments.
CONFERENCE CALL
savient will host a live web cast to review fourth quarter...international)
Conf ID: 5547271
ABOUT
savient PHARMACEUTICALS, INC.
...
Pegloticase BLA Filing Accepted for Priority Review by FDA
...BRUNSWICK, N.J., Dec. 29 /PRNewswire-FirstCall/ --
savient Pharmaceuticals, Inc. (Nasdaq: SVNT ) today anno...e gout, under the auspices of an SPA from the FDA.
savient has licensed exclusive worldwide rights to the tec...f Mountain View Pharmaceuticals, Inc.
ABOUT
savient PHARMACEUTICALS, INC.
...
Savient Pharmaceuticals to Present at the 27th Annual J.P. Morgan Healthcare Conference on January 14th
... BRUNSWICK, N.J., Dec. 8 /PRNewswire-FirstCall/ --
savient Pharmaceuticals, Inc. (Nasdaq: SVNT ) today announced that Paul Hamelin, President of
savient Pharmaceuticals will be presenting at the upcoming...by logging on to the Investor Relations section of
savient Pharmaceuticals' web site, http://www.savient.com...
Savient's Board of Directors Forms a Board Committee to Oversee the Regulatory and Pre-Launch Activities for Pegloticase
...BRUNSWICK, N.J., Nov. 19 /PRNewswire-FirstCall/ --
savient Pharmaceuticals, Inc. (Nasdaq: SVNT ) today anno...he Committee. The Committee will work closely with
savient officers, Dr. Robert Lamm and Dr. Zeb Horowitz, wh...sight Committee will play a key role in supporting
savient during this important time as we work toward FDA a...
Savient Pharmaceuticals to Present at the Credit Suisse Phoenix Healthcare Conference on November 13th
...
Clement, President and Chief Executive Officer of
savient Pharmaceuticals,
will present a corporate update a...by logging
on to the Investor Relations section of
savient Pharmaceuticals' web site,
http://www.savient.com...ble on the
company's web site for 30 days.
ABOUT
savient PHARMACEUTICALS, INC.
...
New Drug Helps Relieve Gout
...e blood to target levels within a few hours in most patients.
That's the conclusion of a study by researchers at Duke University Medical Center and
savient Pharmaceuticals, the company that's developing the drug.
The phase II clinical trial included 41 patients randomly selected to receive either four...
NBA Coach Maurice Cheeks Teams Up with the Gout & Uric Acid Education Society (GUAES) to Call a 'Time Out for Gout'
...rs are encouraged to support the educational outreach of
the Society. Event sponsorship has been provided to the Gout & Uric Acid
Education Society by
savient Pharmaceuticals, Inc. and TAP Pharmaceutical
Products, Inc.
Media Contact: Elizabeth Baxter
212-367-6875 Eliza...
Savient in Medical Technology
Savient Provides Update on Pegloticase BLA
...BRUNSWICK, N.J., Feb. 12 /PRNewswire-FirstCall/ --
savient Pharmaceuticals, Inc. (Nasdaq: SVNT ) today anno...y scheduled for March 5, 2009 will be rescheduled.
savient will provide additional details regarding the resc...e gout, under the auspices of an SPA from the FDA.
savient has licensed exclusive worldwide rights to the tec...
Savient Announces FDA's Advisory Panel to Review Pegloticase for Treatment-Failure Gout Patients
...BRUNSWICK, N.J., Jan. 28 /PRNewswire-FirstCall/ --
savient Pharmaceuticals, Inc. (Nasdaq: SVNT ) today anno...ed for a drug of a new therapeutic class.
savient submitted its BLA to the FDA on October 31, 2008 s...rug designation by the FDA in 2001.
ABOUT
savient PHARMACEUTICALS, INC.
...
Savient Pharmaceuticals Announces Acceptance of Two Gout-Related
Abstracts for Poster Presentation at the European League Against
Rheumatism (EULAR) 2007 Annual Congress
...ease visit
the Congress website at www.eular.org
savient licensed exclusive, worldwide rights to the techno...ark of Mountain View
Pharmaceuticals, Inc.
ABOUT
savient PHARMACEUTICALS
savient Pharmaceuticals is a biopharmaceutical company eng...
Savient in Biological Technology
FDA Appointed Arthritis Advisory Committee Recommends U.S. Food and Drug Administration Approval for KRYSTEXXA(TM) for Refractory Chronic Gout
...
savient to Host Conference Call and Webcast on Wednesday, ...BRUNSWICK, N.J., June 16 /PRNewswire-FirstCall/ --
savient Pharmaceuticals, Inc. (Nasdaq: SVNT ) announced ...ffering from TFG," said Paul Hamelin, President of
savient Pharmaceuticals, Inc. "KRYSTEXXA has the potentia...
Savient Announces New Date for FDA Arthritis Advisory Panel Review of KRYSTEXXA(TM) for Treatment Failure Gout
...T BRUNSWICK, N.J., May 7 /PRNewswire-FirstCall/ --
savient Pharmaceuticals, Inc. (Nasdaq: SVNT ) today anno...from the open label extension study.
ABOUT
savient PHARMACEUTICALS, INC.
savient Pharmaceuticals, Inc. is a specialty biopharmaceut...
Savient Pharmaceuticals Reports First Quarter 2009 Financial Results
...T BRUNSWICK, N.J., May 6 /PRNewswire-FirstCall/ --
savient Pharmaceuticals, Inc. (Nasdaq: SVNT ) today repo...on these investments.
CONFERENCE CALL
savient will host a live web cast to review first quarter ... (international)
Conf ID: 4393613
ABOUT
savient PHARMACEUTICALS, INC.
...
Disability and Poor Quality of Life Associated With Treatment Failure Gout Patients
...T BRUNSWICK, N.J., May 5 /PRNewswire-FirstCall/ --
savient Pharmaceuticals, Inc. (Nasdaq: SVNT ) announced ...same metrics reported by physicians.
About
savient Pharmaceuticals, Inc.
savient Pharmaceuticals, Inc. is a specialty biopharmaceut...
Savient Pharmaceuticals to Raise $31 Million Through Registered Direct Offering
...BRUNSWICK, N.J., April 3 /PRNewswire-FirstCall/ --
savient Pharmaceuticals, Inc. (Nasdaq: SVNT ) today anno...sion web site at http://www.sec.gov , or from
savient Pharmaceuticals, Inc. at One Tower Center, 14th Fl... and warrants described above are being offered by
savient pursuant to a registration statement previously fi...
Savient Pharmaceuticals to Hold Fourth Quarter and Year-End 2008 Results Conference Call on Thursday, February 26, 2009
...o so by visiting the Investor Relations section of
savient Pharmaceuticals' web site at http://www.savient.c...entering conference ID number 5547271.
ABOUT
savient PHARMACEUTICALS, INC.
savient Pharmaceuticals, Inc. is a biopharmaceutical compa...
Savient Announces Appointment of David Gionco as Chief Financial Officer
...BRUNSWICK, N.J., Feb. 12 /PRNewswire-FirstCall/ --
savient Pharmaceuticals, Inc. (Nasdaq: SVNT ) today anno...step in as Chief Financial Officer. Since joining
savient in 2006, David has distinguished himself as a true...(TM) (pegloticase)," said Paul Hamelin, President,
savient Pharmaceuticals.
Mr. Gionco has spent more th...
Savient Pharmaceuticals to Present at the Lazard Capital Markets 5th Annual Healthcare Conference on November 18th
...
Clement, President and Chief Executive Officer of
savient Pharmaceuticals
will present a corporate update at...by logging
on to the Investor Relations section of
savient Pharmaceuticals' web site,
http://www.savient.com...ble on the
company's web site for 30 days.
ABOUT
savient PHARMACEUTICALS, INC.
...
Savient Pharmaceuticals Reports Third Quarter 2008 Financial Results
...s earned on these
investments.
CONFERENCE CALL
savient will host a live web cast to review third quarter ...5-9291 (international)
Conf ID: 67897749
ABOUT
savient PHARMACEUTICALS, INC.
savient Pharmaceuticals is a biopharmaceutical company eng...
Savient Submits Biologics License Application (BLA) for pegloticase
...egloticase for an extended period
of time.
ABOUT
savient PHARMACEUTICALS, INC.
savient Pharmaceuticals is a biopharmaceutical company eng...nd the BLA was filed with the FDA in October 2008.
savient has exclusively
licensed worldwide rights to the t...